胰腺癌治疗进展英文讲解材料.pptVIP

Howard A. Reber, MD Professor of Surgery UCLA School of Medicine;Pancreatic CancerEpidemiology ;Pancreatic CancerEpidemiology ;Pancreatic CancerEpidemiology ;Pancreatic CancerEpidemiology ;Late Presentation - Poor Survival;Late Presentation - Poor Survival;No Surgery ;Standard Whipple;Standard Whipple;Pylorus Preserving Whipple;Pylorus Preserving Whipple;Factors Influencing Survival ;182 consecutive patients underwent a Whipple for pancreatic cancer between 1987 and 2005. Patients from 1987-1995 were compared with those from 1996-2005.;;Survival;Degree of Tumor Differentiation;Lymph Nodes;Perineural Invasion;Resection Margins;27.4%;;350 ml EBL;Adjuvant Therapy;;Criteria for Resection;Criteria for Resection;“Downstaging” of PaCa;Effect of Chemotherapy on Tumor;Initial scan shows SMA involvement;PV;;Adjuvant Therapy;Neoadjuvant Therapy;Theoretical Advantages;Theoretical Advantages;;Theoretical Advantages of Neoadjuvant Therapy;Is This an Advantage?;Neoadjuvant Therapy ;Neoadjuvant Therapy ;Neoadjuvant Therapy ;Neoadjuvant RadioTherapy ;;David Geffen School of Medicine at UCLA 1955 - 2014;Ronald Reagan UCLA Medical Center;Howard A. Reber, MD Professor of Surgery UCLA School of Medicine